Incidence, Predictors, and Outcomes of Post-Percutaneous Coronary Intervention Nephropathy in Patients With Diabetes Mellitus and Normal Baseline Serum Creatinine Levels

American Journal of Cardiology

Volumn 101, Issue 11, 2008, Pages 1544-1549

  Roy, Probal ^a   Raya, Vikram ^a   Okabe, Teruo ^a   Pinto Slottow, Tina L ^a   Steinberg, Daniel H ^a   Smith, Kimberly ^a   Xue, Zhenyi ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Suddath, William O ^a   Pichard, Augusto D ^a   Lindsay, Joseph ^a   Waksman, Ron ^a  

^a Washington Hospital Center   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; BODY MASS; CARDIOGENIC SHOCK; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIALYSIS; FALSE ANEURYSM; FEMALE; HAZARD RATIO; HEART DISEASE; HEART MUSCLE REVASCULARIZATION; HEMATOMA; HUMAN; INCIDENCE; KIDNEY DISEASE; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SEX RATIO; TIME SERIES ANALYSIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CORONARY DISEASE; CREATININE; DIABETES COMPLICATIONS; DISTRICT OF COLUMBIA; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; INCIDENCE; KIDNEY DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 43549094666     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.02.035     Document Type: Article

References (14)

1. McCullough P.A., Adam A., Becker C.R., Davidson C., Lameire N., Stacul F., Tumlin J., and CIN Consensus Working Panel. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 98 suppl (2006) 5K-13K
2. Levy E.M., Viscoli C.M., and Horwitz R.I. The effect of acute renal failure on mortality. A cohort analysis. JAMA 275 (1996) 1489-1494
3. Rihal C.S., Textor S.C., Grill D.E., Berger P.B., Ting H.H., Best P.J., Singh M., Bell M.R., Barsness G.W., Mathew V., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105 (2002) 2259-2264
4. McCullough P.A., Wolyn R., Rocher L.L., Levin R.N., and O'Neill W.W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103 (1997) 368-375
5. Lindsay J., Apple S., Pinnow E.E., Gevorkian N., Gruberg L., Satler L.F., Pichard A.D., Kent K.M., Suddath W., and Waksman R. Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine. Catheter Cardiovasc Interv 59 (2003) 338-343
6. Mehran R., Aymong E.D., Nikolsky E., Lasic Z., Iakovou I., Fahy M., Mintz G.S., Lansky A.J., Moses J.W., Stone G.W., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44 (2004) 1393-1399
7. Dangas G., Iakovou I., Nikolsky E., Aymong E.D., Mintz G.S., Kipshidze N.N., Lansky A.J., Moussa I., Stone G.W., Moses J.W., et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 95 (2005) 13-19
8. Parfrey P.S., Griffiths S.M., Barrett B.J., Paul M.D., Genge M., Withers J., Farid N., and McManamon P.J. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 321 (1989) 395-397
9. Harding M.B., Davidson C.J., Pieper K.S., Hlatky M., Schwab S.J., Morris K.G., Hermiller J.B., and Bashore T.M. Comparison of cardiovascular and renal toxicity after cardiac catheterization using a nonionic versus ionic radiographic contrast agent. Am J Cardiol 68 (1991) 1117-1119
10. Nikolsky E., Mehran R., Turcot D., Aymong E.D., Mintz G.S., Lasic Z., Lansky A.J., Tsounias E., Moses J.W., Stone G.W., et al. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 94 (2004) 300-305
11. Nikolsky E., Mehran R., Lasic Z., Mintz G.S., Lansky A.J., Na Y., Pocock S., Negoita M., Moussa I., Stone G.W., et al. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 67 (2005) 706-713
12. McCullough P.A., Adam A., Becker C.R., Davidson C., Lameire N., Stacul F., Tumlin J., and CIN Consensus Working Panel. Risk prediction of contrast-induced nephropathy. Am J Cardiol 98 suppl (2006) 27K-36K
13. Iakovou I., Dangas G., Mehran R., Lansky A.J., Ashby D.T., Fahy M., Mintz G.S., Kent K.M., Pichard A.D., Satler L.F., et al. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol 15 (2003) 18-22
14. Mueller C., Buerkle G., Perruchoud A.P., and Buettner H.J. Female sex and risk of contrast nephropathy after percutaneous coronary intervention. Can J Cardiol 20 (2004) 505-509